Mike Proulx, Research Director at Forrester, shares new data on how companies feel about using AI programs like ChatGPT.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Nick Kyrgios posts Instagram picture with smoking Mike Tyson and teases projectNick Kyrgios has teased a project with former heavyweight world champion Mike Tyson. Australian Kyrgios posted a picture with Iron Mike on social media as the pair met up at the Ultimate Tennis Sho…
Lire la suite »
Bibliometric analysis reveals research trends connecting Alzheimer's disease and the gut microbiomeBibliometric analysis reveals research trends connecting Alzheimer's disease and the gut microbiome Nutrients_MDPI Alzheimers Alzheimersdisease disease microbiome gut gutmicrobiome
Lire la suite »
Addressing research gaps: The UK's efforts to study lung cancer in never smokersAddressing research gaps: The UK's efforts to study lung cancer in never smokers Nature uniofleicester researchgaps lungcancer cancer lung smokers neversmokers publichealth
Lire la suite »
New research reveals tech companies aren’t doing enough to tackle digital misogynoirA new report from Glitch calls for immediate action to tackle online abuse against Black women (also known as digital misogynoir).
Lire la suite »
Worldcoin: ChatGPT boss's crypto project that scans people's eyeballs being looked at by UK regulatorWorldcoin launched on Monday in cities including London, where pop-up sites had people queuing up to scan their eyeballs using a silver orb. They receive some free cryptocurrency in return, and it's said to be the basis of a new form of digital ID designed for the AI era.
Lire la suite »
The role of CD180 in hematological malignancies and inflammatory disorders - Molecular MedicineToll-like receptors play a significant role in the innate immune system and are also involved in the pathophysiology of many different diseases. Over the past 35 years, there have been a growing number of publications exploring the role of the orphan toll-like receptor, CD180. We therefore set out to provide a narrative review of the current evidence surrounding CD180 in both health and disease. We first explore the evidence surrounding the role of CD180 in physiology including its expression, function and signaling in antigen presenting cells (APCs) (dendritic cells, monocytes, and B cells). We particularly focus on the role of CD180 as a modulator of other TLRs including TLR2, TLR4, and TLR9. We then discuss the role of CD180 in inflammatory and autoimmune diseases, as well as in hematological malignancies of B cell origin, including chronic lymphocytic leukemia (CLL). Based on this evidence we produce a current model for CD180 in disease and explore the potential role for CD180 as both a prognostic biomarker and therapeutic target. Throughout, we highlight specific areas of research which should be addressed to further the understanding of CD180 biology and the translational potential of research into CD180 in various diseases.
Lire la suite »